{
  "docId": "019f6b8e-fcff-749d-9e42-455320e9fd38",
  "docSlug": "jarvis-beckley-psytech-pitch-deck",
  "documentTitle": "Beckley Psytech Pitch Deck",
  "authorId": "beckley-psytech-pitch-deck",
  "authorName": null,
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": null,
  "orientation": null,
  "aspectRatio": null,
  "pageNumber": 5,
  "pageCount": 22,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a hexagonal layout to present four key pillars of the company's value proposition.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019f6b8e-fcff-749d-9e42-455320e9fd38/5",
  "deckHref": "/decks/019f6b8e-fcff-749d-9e42-455320e9fd38",
  "deckJsonHref": "/decks/019f6b8e-fcff-749d-9e42-455320e9fd38.json",
  "deckAnchorHref": "/decks/019f6b8e-fcff-749d-9e42-455320e9fd38#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.25,
        "x": 0.3,
        "y": 0.45
      },
      "kind": "list",
      "text": "02: Team combines unmatched psychedelic research and drug development expertise and has proven track-record of success in biotech startups.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "07e1731d-0bea-4c0d-9a5b-04d1e0d4599c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.25,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "01: Developing psychedelic compounds as a transformative new class of medicine for neuropsychiatric diseases.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7bb86cb8-214c-4e00-82bd-538423c7b85b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.2,
        "x": 0.75,
        "y": 0.5
      },
      "kind": "list",
      "text": "04: Company is raising $18m to advance core programs through key development milestones as set out in this presentation.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "861d7a25-83ad-497b-b707-8ed3358a1173",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.25,
        "x": 0.55,
        "y": 0.2
      },
      "kind": "list",
      "text": "03: Drug development platform approach to manage risk and maximise commercial value.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cb008b2d-235b-4daf-aeee-f9abc97e29f3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Beckley Psytech: A leading Psychedelic Drug Development Platform positioned for significant growth",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1c3ebbca-a6c9-4804-8507-cb8f9960a896",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "0b62e731-a46b-4f5c-8efd-b424d56d436d",
      "evidence": "This slide provides a brief summary of the company's goals and objectives.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}